25.11.2019
EN
Official Journal of the European Union
C 399/99
Action brought on 4 October 2019 – Health Product Group v EUIPO – Bioline Pharmaceutical (Enterosgel)
(Case T-678/19)
(2019/C 399/117)
Language of the case: English
Parties
Applicant: Health Product Group sp. z o.o. (Warsaw, Poland) (represented by: M. Kondrat, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Bioline Pharmaceutical AG (Baar, Switzerland)
Details of the proceedings before EUIPO
Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal
Trade mark at issue: International registration designating the European Union in respect of the word mark Enterosgel – International registration designating the European Union No 896 788
Procedure before EUIPO: Cancellation proceedings
Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 8 August 2019 in Case R 482/2018-4
Form of order sought
The applicant claims that the Court should:
—
annul the contested decision and cancel the trade mark;
—
award the costs in applicant’s favour.
Plea in law
—
Infringement of Article 59(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.
Full & Egal Universal Law Academy